Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:16:39.163Z.
Calculation as of: 2026-10-06T16:16:39.163Z.
Quote observation: 2026-10-06T16:14:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Electra Therapeutics Inc.
Market Cap
$202.26M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$206.04M
Free Cash Flow Yield
3.34%
TTM Avg
3.60%
3Y Avg
5.22%
5Y Avg
5.17%
Market Cap
$209.49M
Free Cash Flow Yield
N/A
TTM Avg
10.09%
3Y Avg
10.09%
5Y Avg
10.09%
Market Cap
$191.81M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$214.34M
Free Cash Flow Yield
2.65%
TTM Avg
2.46%
3Y Avg
2.61%
5Y Avg
2.53%
Market Cap
$214.21M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$215.15M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $202.26M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $206.04M | 3.34% | 3.60% | 5.22% | 5.17% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $209.49M | N/A | 10.09% | 10.09% | 10.09% |
| RxSight, Inc. (RXST)vs › | $194.56M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $191.81M | N/A | N/A | N/A | N/A |
| Niagen Bioscience Inc (NAGE)vs › | $214.34M | 2.65% | 2.46% | 2.61% | 2.53% |
| Compugen Ltd. (CGEN)vs › | $213.22M | N/A | N/A | N/A | N/A |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.21M | N/A | N/A | N/A | N/A |
| Lyell Immunopharma, Inc. (LYEL)vs › | $215.15M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $218.62M | N/A | 41.32% | 41.21% | 35.11% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
